Procédé de préparation de nouvelles chloroquinoléines
1,158,868. 4 - [(21 - Alkoxycarbonyl) - phenylamino] - quinoline derivatives. ROUSSEL UCLAF. 16 Feb., 1968 [22 Feb., 1967], No. 7819/68. Heading C2C. Novel 4 - [(21 - alkoxycarbonyl) - phenylamino] - quinoline derivatives of the general formula wherein R is a methyl or phenyl radical and R 1 is a C...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ALLAIS,ANDRE |
description | 1,158,868. 4 - [(21 - Alkoxycarbonyl) - phenylamino] - quinoline derivatives. ROUSSEL UCLAF. 16 Feb., 1968 [22 Feb., 1967], No. 7819/68. Heading C2C. Novel 4 - [(21 - alkoxycarbonyl) - phenylamino] - quinoline derivatives of the general formula wherein R is a methyl or phenyl radical and R 1 is a C 1-8 alkyl radical, an α- or #-glyceryl group or a furfuryl or methoxycarbonylmethyl group, the chlorine atom in the quinoline ring system being in the 7- or 8-position, and physiologically acceptable acid addition salts thereof are prepared by condensation under acidic conditions of an alkyl anthranilate derivative of the general formula with a 4,7- or 4,8-dichloroquinoline derivative of the general formula followed optionally by conversion of the resulting acid addition salt to the corresponding free base or a physiologically acceptable salt thereof. Pharmaceutical compositions having antiinflammatory activity comprise, as active ingredient, at least one 4-[(21-alkoxycarbonyl)- phenylamino]-quinoline derivative of the first general formula above or physiologically acceptable acid addition salt thereof, in association with a pharmaceutical carrier or excipient, and may be administered orally, transcutaneously, rectally or topically. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CH486461A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CH486461A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CH486461A3</originalsourceid><addsrcrecordid>eNrjZLAMKMpPPrwy5fBKhZRUhYKiwysLEosSSzLz80D8vPzSstScnNRiheSMnPyi_MLSzLz8nMMrM_NSi3kYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxQWJyal5qSbyzh4mFmYmZoaMxQQUAoYwwrQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Procédé de préparation de nouvelles chloroquinoléines</title><source>esp@cenet</source><creator>ALLAIS,ANDRE</creator><creatorcontrib>ALLAIS,ANDRE</creatorcontrib><description>1,158,868. 4 - [(21 - Alkoxycarbonyl) - phenylamino] - quinoline derivatives. ROUSSEL UCLAF. 16 Feb., 1968 [22 Feb., 1967], No. 7819/68. Heading C2C. Novel 4 - [(21 - alkoxycarbonyl) - phenylamino] - quinoline derivatives of the general formula wherein R is a methyl or phenyl radical and R 1 is a C 1-8 alkyl radical, an α- or #-glyceryl group or a furfuryl or methoxycarbonylmethyl group, the chlorine atom in the quinoline ring system being in the 7- or 8-position, and physiologically acceptable acid addition salts thereof are prepared by condensation under acidic conditions of an alkyl anthranilate derivative of the general formula with a 4,7- or 4,8-dichloroquinoline derivative of the general formula followed optionally by conversion of the resulting acid addition salt to the corresponding free base or a physiologically acceptable salt thereof. Pharmaceutical compositions having antiinflammatory activity comprise, as active ingredient, at least one 4-[(21-alkoxycarbonyl)- phenylamino]-quinoline derivative of the first general formula above or physiologically acceptable acid addition salt thereof, in association with a pharmaceutical carrier or excipient, and may be administered orally, transcutaneously, rectally or topically.</description><edition>1</edition><language>fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>1970</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19700228&DB=EPODOC&CC=CH&NR=486461A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19700228&DB=EPODOC&CC=CH&NR=486461A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ALLAIS,ANDRE</creatorcontrib><title>Procédé de préparation de nouvelles chloroquinoléines</title><description>1,158,868. 4 - [(21 - Alkoxycarbonyl) - phenylamino] - quinoline derivatives. ROUSSEL UCLAF. 16 Feb., 1968 [22 Feb., 1967], No. 7819/68. Heading C2C. Novel 4 - [(21 - alkoxycarbonyl) - phenylamino] - quinoline derivatives of the general formula wherein R is a methyl or phenyl radical and R 1 is a C 1-8 alkyl radical, an α- or #-glyceryl group or a furfuryl or methoxycarbonylmethyl group, the chlorine atom in the quinoline ring system being in the 7- or 8-position, and physiologically acceptable acid addition salts thereof are prepared by condensation under acidic conditions of an alkyl anthranilate derivative of the general formula with a 4,7- or 4,8-dichloroquinoline derivative of the general formula followed optionally by conversion of the resulting acid addition salt to the corresponding free base or a physiologically acceptable salt thereof. Pharmaceutical compositions having antiinflammatory activity comprise, as active ingredient, at least one 4-[(21-alkoxycarbonyl)- phenylamino]-quinoline derivative of the first general formula above or physiologically acceptable acid addition salt thereof, in association with a pharmaceutical carrier or excipient, and may be administered orally, transcutaneously, rectally or topically.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1970</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAMKMpPPrwy5fBKhZRUhYKiwysLEosSSzLz80D8vPzSstScnNRiheSMnPyi_MLSzLz8nMMrM_NSi3kYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxQWJyal5qSbyzh4mFmYmZoaMxQQUAoYwwrQ</recordid><startdate>19700228</startdate><enddate>19700228</enddate><creator>ALLAIS,ANDRE</creator><scope>EVB</scope></search><sort><creationdate>19700228</creationdate><title>Procédé de préparation de nouvelles chloroquinoléines</title><author>ALLAIS,ANDRE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CH486461A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>1970</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>ALLAIS,ANDRE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ALLAIS,ANDRE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Procédé de préparation de nouvelles chloroquinoléines</title><date>1970-02-28</date><risdate>1970</risdate><abstract>1,158,868. 4 - [(21 - Alkoxycarbonyl) - phenylamino] - quinoline derivatives. ROUSSEL UCLAF. 16 Feb., 1968 [22 Feb., 1967], No. 7819/68. Heading C2C. Novel 4 - [(21 - alkoxycarbonyl) - phenylamino] - quinoline derivatives of the general formula wherein R is a methyl or phenyl radical and R 1 is a C 1-8 alkyl radical, an α- or #-glyceryl group or a furfuryl or methoxycarbonylmethyl group, the chlorine atom in the quinoline ring system being in the 7- or 8-position, and physiologically acceptable acid addition salts thereof are prepared by condensation under acidic conditions of an alkyl anthranilate derivative of the general formula with a 4,7- or 4,8-dichloroquinoline derivative of the general formula followed optionally by conversion of the resulting acid addition salt to the corresponding free base or a physiologically acceptable salt thereof. Pharmaceutical compositions having antiinflammatory activity comprise, as active ingredient, at least one 4-[(21-alkoxycarbonyl)- phenylamino]-quinoline derivative of the first general formula above or physiologically acceptable acid addition salt thereof, in association with a pharmaceutical carrier or excipient, and may be administered orally, transcutaneously, rectally or topically.</abstract><edition>1</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | fre |
recordid | cdi_epo_espacenet_CH486461A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
title | Procédé de préparation de nouvelles chloroquinoléines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A22%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ALLAIS,ANDRE&rft.date=1970-02-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECH486461A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |